if COVID is successful MSB is targeting 10,000 patients in first 6 months (using existing facilities of partners) - main challenge will be raw materials - will require investment/collaboration with vendors of raw materials.
Also indicated that current plan is to build out new spaces rather than move to 3D bioreactors
Singapore will fully supply US paediatric SR-aGVHD
if COVID is successful MSB is targeting 10,000 patients in first...
-
- There are more pages in this discussion • 639 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |